Cameroon vs Ethiopia: HIV/AIDS deaths averted by antiretroviral therapy
Cameroon
29,674 deaths
in 2024
Ethiopia
27,746 deaths
in 2024
Cameroon rank
12th
Ethiopia rank
13th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cameroon
- Ethiopia
How they compare
Cameroon currently reports 29,674 deaths against 27,746 deaths in Ethiopia, a difference of 1,928 deaths.
That makes Cameroon's figure about 1.1 times Ethiopia's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Ethiopia ahead.
Cameroon ranks 12th and Ethiopia ranks 13th of 157 countries.
Ethiopia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cameroon | Ethiopia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 4,683 deaths | 9,193 deaths | 4,510 deaths | Ethiopia |
| 2010s | 17,909 deaths | 33,113 deaths | 15,205 deaths | Ethiopia |
| 2020s | 28,409 deaths | 29,478 deaths | 1,069 deaths | Ethiopia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cameroon or Ethiopia?
- Cameroon, at 29,674 deaths against 27,746 deaths in Ethiopia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cameroon and Ethiopia?
- 1,928 deaths, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Ethiopia?
- 35 years are reported by both, from 1990 to 2024.
- How do Cameroon and Ethiopia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cameroon ranks 12th and Ethiopia ranks 13th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.